Skip to content
Governance Register

← US public companies

Evommune, Inc.

SEC CIK 2044725 · EVMN · last insider filing 2026-06-24

Directors (from insider filings)

NameCapacity as filedFilings
Pena Luis C. Director · President & CEO filed 2025 - 2026
Mcgraw Benjamin F III Director filed 2025 - 2026
Kirsch Arthur S Director filed 2025 - 2026
Cohen David E Director filed 2025 - 2026
Bauer Eugene Director · Chief Medical Officer filed 2025 - 2026
LSP 7 Cooperative UA Director filed 2025 - 2026
Verduyn-van Weegen Felice Isabel Director filed 2025 - 2026
RA Capital Healthcare Fund LP Director filed 2025 - 2026
RA Capital Management, LLC Director filed 2025 - 2026
Kolchinsky Peter Director filed 2025 - 2026
Shah Rajeev M. Director filed 2025 - 2026
RA Capital Nexus Fund III, L.P. Director filed 2025 - 2026
Hopfner Robert Lorne Director filed 2025 - 2025
Pivotal Bioventure Partners Fund I, L.P. Director filed 2025 - 2025
Pivotal Bioventure Partners Fund I U.G.P., Ltd Director filed 2025 - 2025
Pivotal Bioventure Partners Fund I G.P., L.P. Director filed 2025 - 2025
Dirocco Derek Director filed 2025 - 2025

Officers (from insider filings)

NameTitle as filedFilings
Drew Janice Suzann EVP, Operations filed 2025 - 2026
Patel Jeegar Pravinkumar Chief Scientific Officer filed 2025 - 2026
Moss Gregory S. Chief Business & Legal Officer filed 2025 - 2026
Carver Kyle Chief Financial Officer filed 2025 - 2026

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.